Milk-Based Nano-Capsules Loaded with Antimicrobial Peptide and Anti-Inflammatory Nanobody Treat Colitis in Mice

The researchers engineered milk-derived extracellular vesicles by fusing a cell-penetrating peptide (TAT) to cargo proteins to enable loading. They tested protection against gastrointestinal degradation in vitro and in vivo. Acute UC was modeled in mice to test EVVHH, measuring tissue TNF-α and pathology. Chronic UC was modeled to test the dual-loaded EVLV formulation, assessing intestinal barrier function, inflammation, microbiota composition, and behavioral symptoms (depression/anxiety).

Current biologic treatments for IBD typically require injection and cannot be taken orally because they are destroyed in the gut. This study demonstrates a practical oral delivery system using naturally occurring milk vesicles that are safe, scalable, and can carry multiple therapeutic agents simultaneously. The combination of anti-inflammatory and antimicrobial peptide payloads addresses both hallmarks of UC — inflammation and dysbiosis — in a single oral formulation.

This study sits at the intersection of three active research fields: extracellular vesicle therapeutics, antimicrobial peptide therapy, and oral biologic delivery. Milk-derived EVs are particularly attractive because milk is abundant, safe, and the vesicles have natural stability in the gut. If this approach translates to humans, it could transform IBD treatment by replacing injected biologics with oral formulations — a major improvement in patient quality of life and treatment adherence.

All experiments were conducted in mice, and the complexity of human UC — including its chronic relapsing nature and heterogeneous presentation — may not be fully captured by murine models. The scalability and consistency of milk-derived EV production for clinical use is not addressed. Long-term safety of repeated oral EV administration is unknown. The behavioral improvements (anxiety/depression) were measured in mouse models with limited translatability to human neuropsychiatric symptoms.